Short Read Sequencing Market is predicted to reach USD 27.2 billion at a CAGR of 19.20% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Short Read Sequencing Market”.

The Short-Read Sequencing market is estimated to register a CAGR of 19.20% during the forecast period of 2024 to 2032.

MRFR recognizes the following companies as the key players in the global Short-Read Sequencing market— Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., BGI, QIAGEN, Agilent Technologies, PerkinElmer, Inc., ProPhase Labs, Inc., Psomagen and Azenta US Inc.

Market Highlights

The global Short-Read Sequencing market is accounted to register a CAGR of 19.20% during the forecast period and is estimated to reach USD 27.2 billion by 2032.

The Short-Read Sequencing market is experiencing growth due to several factors. Advances in sequencing technologies have led to reduced costs and increased throughput, making sequencing more accessible to researchers and clinicians. Additionally, the growing application of short-read sequencing in genomics research, personalized medicine, and clinical diagnostics is driving demand. Moreover, collaborations between academia, industry, and government organizations are fostering innovation and driving the expansion of the Short-Read Sequencing market.

Access Full Report @ https://www.marketresearchfuture.com/reports/short-read-sequencing-market-21876

Segment Analysis

The global Short-Read Sequencing market has been segmented based on Product, Workflow, Application and End-Use.

On the basis of Product, the market is segmented into Instruments, Consumables and Services. The Instruments category dominated the Short-Read Sequencing Market due to their essential role in sequencing workflows. These products, including sequencers and associated instrumentation, enable the generation of short-read sequencing data with high accuracy and throughput. The increasing adoption of next-generation sequencing technologies and the demand for efficient sequencing platforms contributed to the largest market share of Instruments Products in 2023.

Based on Workflow, the global Short-Read Sequencing market has been segmented into Pre-Sequencing, Sequencing and Data Analysis. The Pre-Sequencing segment emerged as the dominant category in the Short-Read Sequencing Market due to its critical role in sample preparation and library construction. These processes are essential for generating high-quality sequencing data. The increasing demand for efficient and standardized pre-sequencing solutions, coupled with advancements in automation and workflow optimization, contributed to its largest market share in 2023.

Based on Application, the global Short-Read Sequencing market has been segmented into Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing (-DNA-based, -RNA-based) and Others. The Whole Genome Sequencing (WGS) dominated the Short-Read Sequencing Market due to its comprehensive analysis of an organism's entire genome. WGS provides insights into genetic variations, disease susceptibility, and population genetics, driving its widespread adoption in research, clinical diagnostics, and personalized medicine. The increasing demand for comprehensive genomic information and declining sequencing costs contributed to its largest market share in 2023.

Based on End-Use, the global Short-Read Sequencing market has been segmented into Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others. The Academic & Research Institutes emerged as the dominant End-Use segment in the Short-Read Sequencing Market due to their extensive use of sequencing technologies for genomic research, transcriptomics, and other applications. These institutions often possess the expertise and resources to conduct large-scale sequencing projects, driving their significant demand for short-read sequencing solutions and capturing the largest market share in 2023.

Regional Analysis

The global Short-Read Sequencing market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe Short-Read Sequencing market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Short-Read Sequencing market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Short-Read Sequencing market comprises the Middle East, Africa, and Latin America.

North America dominates the Short-Read Sequencing Market due to various factors. The region boasts advanced healthcare infrastructure, a strong presence of key market players, and significant investments in research and development. Additionally, North America benefits from supportive regulatory frameworks and government funding for genomic research initiatives. Moreover, collaborations between academic institutions, biotechnology companies, and healthcare providers drive innovation and adoption of short-read sequencing technologies, solidifying North America's position as the market leader.

Europe secures the second largest market share in the Short-Read Sequencing Market due to several factors. The region boasts a robust scientific community, advanced healthcare infrastructure, and a strong focus on genomic research. Additionally, Europe benefits from supportive regulatory environments and government investments in genomics initiatives. Moreover, collaborations between research institutions, biotechnology companies, and healthcare providers drive innovation and adoption of short-read sequencing technologies, contributing to Europe's significant presence in the market.

Asia Pacific experiences the highest Compound Annual Growth Rate (CAGR) in the Short-Read Sequencing Market due to several factors. The region witnesses rapid economic development, increasing investments in healthcare infrastructure, and a growing focus on precision medicine and genomic research. Moreover, the rising adoption of sequencing technologies in clinical and research settings, coupled with expanding biotechnology and pharmaceutical industries, drive market growth. Additionally, government initiatives to promote genomics research further fuel the significant growth of the market in Asia Pacific.

Furthermore, the rest of the world's Short-Read Sequencing market is divided into the Middle East, Africa, and Latin America. The Rest of the World region is experiencing growth in the Short-Read Sequencing market due to increasing investments in genomics research, expanding healthcare infrastructure, and rising adoption of sequencing technologies for various applications. Additionally, collaborations and partnerships with international organizations contribute to market expansion in this region.

Key Findings of the Study

• The global Short-Read Sequencing market is expected to reach USD 27.2 billion by 2032, at a CAGR of 19.20% during the forecast period.


• The Asia Pacific region leads as the fastest-growing region in the Short-Read Sequencing market due to rapid advancements in healthcare infrastructure, increasing research and development activities, rising adoption of genomic medicine, and expanding investments in biotechnology.


• Based on application, the Whole Genome Sequencing segment was attributed to holding the largest market in 2023, with an approximate market share of 20–40%.


• Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., BGI,